𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost of Biologics in the Treatment of Juvenile Idiopathic Arthritis: A Factor not to be Overlooked

✍ Scribed by Prince, Femke H. M.; Suijlekom-Smit, Lisette W. A.

Book ID
120299865
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2013
Tongue
English
Weight
296 KB
Volume
15
Category
Article
ISSN
1174-5878

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of biologics in polya
Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs
✍ Wendy J. Ungar; Vania Costa; Rebecca Hancock-Howard; Brian M. Feldman; Ronald M. πŸ“‚ Article πŸ“… 2010 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 150 KB πŸ‘ 2 views

## Abstract ## Objective Juvenile idiopathic arthritis (JIA) is the most common chronic pediatric rheumatic disease and can have long‐term effects leading to disability in adulthood. Biologics are a new class of drugs increasingly used to treat JIA. The primary study objective was to determine the